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INTRODUCTION
Beh et’ s disease (BD) is a multisystem disorder that pre-
sents with recurrent oral and genital ulcerations as well as ocu-
lar lesions (1). Primary hyperaldosteronism, an uncommon
but important cause of secondary hypertension, is confirmed
by demonstrating elevated aldosterone levels in the presence of
suppressed plasma renin activity (PRA) (2). Conn’ s syndrome,
which is caused by an aldosterone-producing adenoma, is the
most frequent cause of primary hyperaldosteronism and ac-
counts for approximately 70% of such cases. The occurrence
of BD in association with neoplasms is very rare but has been
reported (3-12). We report here an unusual association of BD
and Conn’ s syndrome in a middle-aged Korean woman. We
believe this to be the first report of such a case.
CASE REPORT
The patient was a 39-yr-old woman, who had been troubled
by recurrent oral and genital ulcers and erythema nodosum-
like skin lesions since 1994. She had also occasionally experi-
enced localized pain in the right lower quadrant of the abdo-
men, and was diagnosed with intestinal BD in 1997. At that
time, she had a positive pathergy test and posterior uveitis. She
had been treated with prednisolone, sulfasalazine, and col-
chicine. During follow-up in our outpatient clinic, she sud-
denly developed hypertension and hypokalemia, and on De-
cember 11, 2000, was admitted to Chonnam National Uni-
versity Hospital for further investigation. 
On admission, her blood pressure was 160/120 mmHg,
pulse rate was 70/min, body temperature was 36.5℃, and
respiration rate was 20/min. On physical examination, the
patient appeared chronically ill. The patient’ s laboratory find-
ings were as follows: hemoglobin 10.5 g/dL, white blood cell
count 5,400/ L, platelet count 243,000/ L, C-reactive pro-
tein 0.336 mg/L, erythrocyte sedimentation rate 4 mm/hr,
rheumatoid factor 10.5 IU/mL, C3 92.8 mg/dL, and C4 11.8
mg/dL. Liver function tests were normal, and a test for anti-
nuclear antibody was negative. Serum sodium was 139 mEq/L,
potassium was 3.0 mEq/L, chloride was 105 mEq/L, blood
urea nitrogen was 8.4 mg/dL, and creatinine was 0.9 mg/dL.
A 24-hr urine specimen showed that her urinary potassium
was 52.8 mEq/day and her urinary sodium was 123 mEq/day.
Postural studies revealed suppressed peripheral PRA of 0.53
ng/mL/hr and an elevated aldosterone level of 39.3 ng/dL with
an aldosterone/PRA ratio of 68 in the supine position. After
standing for four hours, her PRA decreased to 0.27 ng/mL/hr,
and her aldosterone level decreased to 31.2 ng/dL. Serum cor-
tisol levels that were measured at the same time were 4.5  g/
dL supine and 8.6  g/dL standing. The plasma ACTH con-
centrations were 12.8 pg/mL and 6.8 pg/mL in the supine and
standing positions, respectively. The levels of urinary cate-
cholamines and their metabolites were normal. An abdominal
ultrasonogram revealed a right adrenal mass measuring 1.5
×2.5 cm. The presence of the mass was confirmed by com-
puted tomography (Fig. 1). 
On February 5, 2001, the patient underwent an abdominal
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exploration. A right total adrenalectomy was performed, with
removal of a 1.5×1×2 cm right adrenal mass that weighed
10 g. On gross examination, the mass was golden-yellow in
color and showed no evidence of necrosis or hemorrhage (Fig.
2). Histologically, the tumor was composed of large, clear, and
finely granular cells in lobular arrangements that were divid-
ed by vascular septae (Fig. 3). The pathological diagnosis was
benign adrenocortical adenoma. The combined biochemical
and pathological profile of the patient was consistent with that
of Conn’ s syndrome. 
Postoperatively, the patient was normotensive, and the se-
rum potassium was 3.7 mEq/L. The patient was discharged
on 12 February 2001 and was followed at the outpatient clin-
ic. Follow-up at 12 months showed that the patient remained
normotensive and normokalemic.
DISCUSSION
BD is endemic in the Middle East and the Mediterranean
region (1). It also occurs in Central and East Asian countries,
such as Korea, Japan, and China. The incidence of BD in Korea
has been increasing (13). The etiology of BD remains unclear,
but genetic and environmental factors probably play a role
in its pathogenesis. 
There have been several reports on concurrent neoplasms in
BD (3-12). However, as far as we know, no association between
BD and Conn’ s syndrome has ever been reported. Previous
case reports provide no documented pathophysiological mech-
anisms for the development of tumors in BD patients, other
than possible drug-related etiologies or the autoimmune nature
of BD itself. Harada et al. (8) suggested that long-term admin-
istration of colchicine in BD patients may induce non-Hog-
kin’ s lymphoma, because of colchicine’ s immunosuppressive
properties. Abe et al. (9) attributed the transformation of lym-
phoma to the immune disturbances of T-helper cells, neutro-
phils, and macrophages in BD. However, the authors believed
that most cases of solid tumors were incidental. 
Fig. 2. The cut surface of the right adrenal mass shows a golden-
yellow color.
Fig. 3. Histologic appearance of the mass. The tumor is composed
of large, clear, and finely granular cells in lobular arrangements (H
&E stain;×400). 
Fig. 1. Computed tomographic scan of the abdomen showing a
right adrenal mass (arrow). 
35Aldosterone-producing adenoma has been recognized as
being second only to renovascular disease as a cause of surgical-
ly correctable hypertension (2). In our patient, the presence
of hypertension, hypokalemia resulting from inappropriate
kaliuresis, suppressed peripheral PRA, increased aldosterone
excretion, and a plasma aldosterone/PRA ratio greater than 30
was consistent with primary aldosteronism (2). Postoperatively,
our patient has remained normotensive and normokalemic.
There have been some reports of high surgical morbidity in
BD. Sayek et al. (14) reported increased surgical morbidity in
seven cases of intestinal BD. Paccagnella et al. (15) reported
a worsening of BD symptoms after surgery, and fatal infection
due to impaired immunity. However, our patient did not expe-
rience any complications.
In conclusion, there is no clear evidence that autoimmune
disorders or immunosuppressive drugs cause epithelial cancer
or adenoma, and therefore, we consider our case to be a sporadic
occurrence of Conn’ s syndrome concurrent with BD.
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